Science and Research

Complement activation induces excessive T cell cytotoxicity in severe COVID-19

Severe COVID-19 is linked to both dysfunctional immune response and unrestrained immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, we combined single-cell transcriptomics and single-cell proteomics with mechanistic studies to assess pathogenic T cell functions and inducing signals. We identified highly activated CD16(+) T cells with increased cytotoxic functions in severe COVID-19. CD16 expression enabled immune-complex-mediated, T cell receptor-independent degranulation and cytotoxicity not found in other diseases. CD16(+) T cells from COVID-19 patients promoted microvascular endothelial cell injury and release of neutrophil and monocyte chemoattractants. CD16(+) T cell clones persisted beyond acute disease maintaining their cytotoxic phenotype. Increased generation of C3a in severe COVID-19 induced activated CD16(+) cytotoxic T cells. Proportions of activated CD16(+) T cells and plasma levels of complement proteins upstream of C3a were associated with fatal outcome of COVID-19, supporting a pathological role of exacerbated cytotoxicity and complement activation in COVID-19.

  • Georg, P.
  • Astaburuaga-García, R.
  • Bonaguro, L.
  • Brumhard, S.
  • Michalick, L.
  • Lippert, L. J.
  • Kostevc, T.
  • Gäbel, C.
  • Schneider, M.
  • Streitz, M.
  • Demichev, V.
  • Gemünd, I.
  • Barone, M.
  • Tober-Lau, P.
  • Helbig, E. T.
  • Hillus, D.
  • Petrov, L.
  • Stein, J.
  • Dey, H. P.
  • Paclik, D.
  • Iwert, C.
  • Mülleder, M.
  • Aulakh, S. K.
  • Djudjaj, S.
  • Bülow, R. D.
  • Mei, H. E.
  • Schulz, A. R.
  • Thiel, A.
  • Hippenstiel, S.
  • Saliba, A. E.
  • Eils, R.
  • Lehmann, I.
  • Mall, M. A.
  • Stricker, S.
  • Röhmel, J.
  • Corman, V. M.
  • Beule, D.
  • Wyler, E.
  • Landthaler, M.
  • Obermayer, B.
  • von Stillfried, S.
  • Boor, P.
  • Demir, M.
  • Wesselmann, H.
  • Suttorp, N.
  • Uhrig, A.
  • Müller-Redetzky, H.
  • Nattermann, J.
  • Kuebler, W. M.
  • Meisel, C.
  • Ralser, M.
  • Schultze, J. L.
  • Aschenbrenner, A. C.
  • Thibeault, C.
  • Kurth, F.
  • Sander, L. E.
  • Blüthgen, N.
  • Sawitzki, B.

Keywords

  • Covid-19
  • T cells
  • complement
  • cytotoxicity
  • immunopathology
Publication details
DOI: 10.1016/j.cell.2021.12.040
Journal: Cell
Work Type: Original
Location: Assoziierter Partner
Disease Area: PALI
Partner / Member: BIH
Access-Number: 35032429

DZL Engagements

chevron-down